Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05068752).
- Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01827371).
- Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: Complete Statistical AnalysisIndependent statistical analysis of Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02329730).
- Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients: Complete Statistical AnalysisIndependent statistical analysis of Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED): Complete Statistical AnalysisIndependent statistical analysis of Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED):…
- Phase IIB TL + YCWP + DC in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Phase IIB TL + YCWP + DC in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02301611).
- Phase III B in Acute Lymphoblastic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Phase III B in Acute Lymphoblastic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03123939).
- Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase III Study of MLN0002 (300 mg) in Treatment of Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Phase IIIb Study of APD421 in Combination as PONV Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of Phase IIIb Study of APD421 in Combination as PONV Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02337062).
- Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China: Complete Statistical AnalysisIndependent statistical analysis of Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase l/II Study of Ruxolitinib for Acute Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Phase l/II Study of Ruxolitinib for Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251965).
- PHE-LEEPIndependent statistical analysis of Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel: Complete Statistical AnalysisIndependent statistical analysis of Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phenylephrine in Spinal Anesthesia in Preeclamptic Patients: Complete Statistical AnalysisIndependent statistical analysis of Phenylephrine in Spinal Anesthesia in Preeclamptic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00458003).
- Phenylephrine Versus Eyelid Taping for Muller’s Muscle-Conjunctival Resection (MMCR) Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05890027).
- Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients: Complete Statistical AnalysisIndependent statistical analysis of Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02203630).
- Phenylephrine vs. Norepinephrine Infusion After Spinal Anesthesia for Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Phenylephrine vs. Norepinephrine Infusion After Spinal Anesthesia for Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354833).
- PHI-05Independent statistical analysis of Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PHM2Independent statistical analysis of Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation: Complete Statistical AnalysisIndependent statistical analysis of PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03933774).
- PHOENIXIndependent statistical analysis of A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX: primary endpoint results, effect estimate with confidence…
- PhoenixIndependent statistical analysis of Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phone Coaching for Weight Loss Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Phone Coaching for Weight Loss Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04293055).
- PHOTO-VIndependent statistical analysis of Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03669042).
- Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01966809).
- Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH: Complete Statistical AnalysisIndependent statistical analysis of Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Physical Activity and Participation: Complete Statistical AnalysisIndependent statistical analysis of Physical Activity and Participation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268916).
- Physical Therapy Intervention for Puerperal Mastitis: Complete Statistical AnalysisIndependent statistical analysis of Physical Therapy Intervention for Puerperal Mastitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569136).
- Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.: Complete Statistical AnalysisIndependent statistical analysis of Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Physiological Flow of Liquids in Healthy Swallowing: Complete Statistical AnalysisIndependent statistical analysis of Physiological Flow of Liquids in Healthy Swallowing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04114617).
- Physiological Flow of Liquids Used in Dysphagia Management (Neuro): Complete Statistical AnalysisIndependent statistical analysis of Physiological Flow of Liquids Used in Dysphagia Management (Neuro): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192358).
- PICASSOIndependent statistical analysis of A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to
- PICLSIndependent statistical analysis of Pregnancy Intervention With a Closed-Loop System (PICLS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774186).
- PICOIndependent statistical analysis of Study to Compare Negative Pressure Wound Therapy or Standard Dressings After Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PIERIndependent statistical analysis of Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PII S3i CAPIndependent statistical analysis of PARTNER II Trial: S3iCAP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02687035).
- PiiitchIndependent statistical analysis of Feasibility of Cocooning Immunization Strategy With Influenza Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570037).
- Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye: Complete Statistical AnalysisIndependent statistical analysis of Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PILLAR IIIIndependent statistical analysis of A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PILOTIndependent statistical analysis of Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PILOTIndependent statistical analysis of Pragmatic Investigation of optimaL Oxygen Targets Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03537937).
- Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06375421).
- Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…